- Home
- TLX vs CROX Comparison
TLX vs CROX Comparison
Compare TLX & CROX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- CROX
- Stock Information
- Founded
- TLX 2015
- CROX 1999
- Country
- TLX Australia
- CROX United States
- Employees
- TLX N/A
- CROX N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- CROX Shoe Manufacturing
- Sector
- TLX Health Care
- CROX Consumer Discretionary
- Exchange
- TLX Nasdaq
- CROX Nasdaq
- Market Cap
- TLX 6.0B
- CROX 5.4B
- IPO Year
- TLX N/A
- CROX 2006
- Fundamental
- Price
- TLX $16.71
- CROX $90.72
- Analyst Decision
- TLX Strong Buy
- CROX Strong Buy
- Analyst Count
- TLX 1
- CROX 12
- Target Price
- TLX $22.00
- CROX $133.73
- AVG Volume (30 Days)
- TLX 28.3K
- CROX 2.3M
- Earning Date
- TLX 01-01-0001
- CROX 05-08-2025
- Dividend Yield
- TLX N/A
- CROX N/A
- EPS Growth
- TLX 798.14
- CROX 24.16
- EPS
- TLX 0.09
- CROX 15.88
- Revenue
- TLX $484,687,790.00
- CROX $4,102,108,000.00
- Revenue This Year
- TLX N/A
- CROX $3.82
- Revenue Next Year
- TLX N/A
- CROX $3.52
- P/E Ratio
- TLX $179.17
- CROX $5.71
- Revenue Growth
- TLX 55.85
- CROX 3.53
- 52 Week Low
- TLX $13.61
- CROX $86.11
- 52 Week High
- TLX $30.36
- CROX $165.32
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- CROX 41.25
- Support Level
- TLX N/A
- CROX $87.35
- Resistance Level
- TLX N/A
- CROX $94.90
- Average True Range (ATR)
- TLX 0.00
- CROX 7.02
- MACD
- TLX 0.00
- CROX -1.39
- Stochastic Oscillator
- TLX 0.00
- CROX 17.29
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company are the United States and other Countries.